Literature DB >> 28164010

Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study.

Alberto Cresti1, Mario Chiavarelli2, Marco Scalese3, Cesira Nencioni4, Silvia Valentini4, Francesco Guerrini1, Incoronata D'Aiello1, Andrea Picchi1, Francesco De Sensi1, Gilbert Habib5.   

Abstract

BACKGROUND: The population at risk, the clinical and microbiological features of infective endocarditis (IE) have changed. Aim of our study was to evaluate the contemporary epidemiological trends, over a 17-year period in a definite region of Tuscany, Italy, to analyze the clinical outcomes and associated prognostic factors.
METHODS: From 1 January 1998 to 31 December 2014, all patients with a definite diagnosis of IE were prospectively entered in a data-base. The Health-Care system data-base was interrogated to capture patients who could have been missed. The final dataset derived by the merging of the two data-bases.
RESULTS: Incidence rate of IE was 4.6/100,000/y with a significant linear incidence increase. In hospitalized patients the incidence was 1.27/1,000 admissions. Over age 65 incidence rate was 11.7/100,000/y. Male/female ratio was 1.54:1. A temporal trend towards an increase in the mean population age was found (P=0.033). There was an increase in the incidence of Health-care associated IE, P=0.016. The most common microorganisms were staphylococcus aureus (25%) and coagulase-negative staphylococci (22%). In-hospital mortality was 24%. A trend towards an increase in mortality rate was found (P=0.055). Independent predictors of mortality were older age, S. aureus infection, heart failure, septic shock and persistent bacteremia.
CONCLUSIONS: Our study confirms an increasing mortality trend in IE, although with a borderline significance. Elderly forms are associated with poor prognosis and higher than 1-year mortality rate even in the multivariate analysis. Ageing population, increase in healthcare-associated and staphylococcal infections, may explain the rise of IE incidence and of the mortality trend.

Entities:  

Keywords:  Infective endocarditis (IE); community-acquired endocarditis; epidemiology; health-care associated endocarditis; temporal trends

Year:  2017        PMID: 28164010      PMCID: PMC5253443          DOI: 10.21037/cdt.2016.08.09

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  31 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

Review 2.  Treatment of infections associated with surgical implants.

Authors:  Rabih O Darouiche
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

Review 3.  A systematic review of population-based studies of infective endocarditis.

Authors:  Imad M Tleyjeh; Ahmed Abdel-Latif; Hazim Rahbi; Christopher G Scott; Kent R Bailey; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

4.  Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.

Authors:  Sadip Pant; Nileshkumar J Patel; Abhishek Deshmukh; Harsh Golwala; Nilay Patel; Apurva Badheka; Glenn A Hirsch; Jawahar L Mehta
Journal:  J Am Coll Cardiol       Date:  2015-05-19       Impact factor: 24.094

5.  Infective endocarditis in Europe: lessons from the Euro heart survey.

Authors:  P Tornos; B Iung; G Permanyer-Miralda; G Baron; F Delahaye; Ch Gohlke-Bärwolf; E G Butchart; P Ravaud; A Vahanian
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

6.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

7.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Authors:  David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell
Journal:  Arch Intern Med       Date:  2009-03-09

8.  Changing profile of infective endocarditis: results of a 1-year survey in France.

Authors:  Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

9.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.

Authors:  D T Durack; A S Lukes; D K Bright
Journal:  Am J Med       Date:  1994-03       Impact factor: 4.965

10.  Excess mortality and morbidity in patients surviving infective endocarditis.

Authors:  Franck Thuny; Roch Giorgi; Raja Habachi; Sebastien Ansaldi; Yvan Le Dolley; Jean-Paul Casalta; Jean-François Avierinos; Alberto Riberi; Sebastien Renard; Frederic Collart; Didier Raoult; Gilbert Habib
Journal:  Am Heart J       Date:  2012-06-13       Impact factor: 4.749

View more
  64 in total

Review 1.  Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy.

Authors:  Rhoia Neidenbach; Koichiro Niwa; Oeztekin Oto; Erwin Oechslin; Jamil Aboulhosn; David Celermajer; Joerg Schelling; Lars Pieper; Linda Sanftenberg; Renate Oberhoffer; Fokko de Haan; Michael Weyand; Stephan Achenbach; Christian Schlensak; Dirk Lossnitzer; Nicole Nagdyman; Yskert von Kodolitsch; Hans-Carlo Kallfelz; David Pittrow; Ulrike M M Bauer; Peter Ewert; Thomas Meinertz; Harald Kaemmerer
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

2.  Infectious endocarditis with jump rope-like vegetations.

Authors:  Tatsuya Shindo; Hiroaki Nishioka
Journal:  Infection       Date:  2018-09-06       Impact factor: 3.553

3.  Methicillin-sensible Staphylococcus aureus causing endocarditis, with cerebral and orthopaedic complications, in a 17-month-old child with no risk factor.

Authors:  Guillaume Geslain; Clara Bourgade; Maryline Chomton; Fleur Le Bourgeois
Journal:  BMJ Case Rep       Date:  2018-10-12

4.  A comparison of different antibiotic regimens for the treatment of infective endocarditis.

Authors:  Arturo J Martí-Carvajal; Mark Dayer; Lucieni O Conterno; Alejandro G Gonzalez Garay; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2020-05-14

5.  An Unusual Case of Neisseria flavescens/subflava Group Tricuspid Valve Endocarditis in a Patient With Previously Treated Methicillin-Resistant Staphylococcus aureus Endocarditis.

Authors:  Anup Solsi; Dawood Findakly; Nawfal Mihyawi; Ayman R Fath
Journal:  Cureus       Date:  2020-08-14

6.  Factors associated with unfavorable outcome in a multicenter audit of 100 infective endocarditis.

Authors:  David Chirio; Marion Le Marechal; Pamela Moceri; Arnaud de la Chapelle; Sylvie Chaillou-Optiz; Anaïs Mothes; Cédric Foucault; Laurence Maulin; Chirine Parsaï; Pierre-Marie Roger; Elisa Demonchy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-15       Impact factor: 3.267

Review 7.  Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: a meta-analysis.

Authors:  Hassan Ishaq; Wajeeha Tariq; Khawaja Muhammad Talha; Bharath Raj Varatharaj Palraj; M Rizwan Sohail; Larry M Baddour; Maryam Mahmood
Journal:  Infection       Date:  2021-01-04       Impact factor: 3.553

8.  Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis.

Authors:  Aubrey Watson; Jun Taek Oh; Karen Sauve; Patricia A Bradford; Cara Cassino; Raymond Schuch
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

9.  Risk Factors for In-Hospital Mortality in Infective Endocarditis.

Authors:  Ana Marques; Inês Cruz; Daniel Caldeira; Sofia Alegria; Ana Catarina Gomes; Ana Luísa Broa; Isabel João; Hélder Pereira
Journal:  Arq Bras Cardiol       Date:  2020-01       Impact factor: 2.000

Review 10.  Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.

Authors:  Katrin Schilcher; Alexander R Horswill
Journal:  Microbiol Mol Biol Rev       Date:  2020-08-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.